Serous Adenocarcinoma of Ovary

Also known as: Ovarian Serous Adenocarcinoma

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00958	Carboplatin	0	Recruiting	1
DB14547	Chloride ion	0	Recruiting	1
DB00515	Cisplatin	0	Recruiting	1
DB01229	Paclitaxel	0	Recruiting	1
DB12257	Platinum	0	Recruiting	1
DB00571	Propranolol	0	Completed	1
DB00062	Albumin human	1	Active Not Recruiting	1
DB17450	Albumin-stabilized nanoparticle (130 nm)	1	Active Not Recruiting	1
DB00112	Bevacizumab	1	Active Not Recruiting	1
DB00112	Bevacizumab	1	Completed	1
DB00188	Bortezomib	1	Completed	1
DB16741	Bortezomib D-mannitol	1	Completed	1
DB00958	Carboplatin	1	Completed	2
DB00515	Cisplatin	1	Completed	1
DB06306	Onalespib	1	Withdrawn	1
DB01229	Paclitaxel	1	Active Not Recruiting	1
DB01229	Paclitaxel	1	Completed	1
DB06809	Plerixafor	1	Completed	1
DB11760	Talazoparib	1	Withdrawn	1
DB07232	Veliparib	1	Completed	1
DB18452	AVB-001	1 / 2	Recruiting	1
DB04849	Cediranib	1 / 2	Active Not Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Active Not Recruiting	1
DB01073	Fludarabine	1 / 2	Active Not Recruiting	1
DB10315	Measles virus vaccine live attenuated	1 / 2	Recruiting	1
DB09074	Olaparib	1 / 2	Active Not Recruiting	1
DB11119	Sodium iodide	1 / 2	Recruiting	1
DB17164	ZB131	1 / 2	Completed	1
DB00112	Bevacizumab	2	Active Not Recruiting	1
DB00112	Bevacizumab	2	Completed	2
DB00112	Bevacizumab	2	Recruiting	1
DB00112	Bevacizumab	2	Terminated	1
DB00958	Carboplatin	2	Completed	1
DB00958	Carboplatin	2	Recruiting	1
DB00531	Cyclophosphamide	2	Completed	1
DB00997	Doxorubicin	2	Active Not Recruiting	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB05719	Elesclomol	2	Completed	1
DB14905	Emactuzumab	2	Terminated	1
DB00441	Gemcitabine	2	Active Not Recruiting	1
DB10315	Measles virus vaccine live attenuated	2	Active Not Recruiting	1
DB09074	Olaparib	2	Active Not Recruiting	1
DB04964	Oregovomab	2	Recruiting	1
DB01229	Paclitaxel	2	Active Not Recruiting	2
DB01229	Paclitaxel	2	Completed	2
DB01229	Paclitaxel	2	Recruiting	1
DB01229	Paclitaxel	2	Terminated	1
DB16694	Pegcetacoplan	2	Recruiting	1
DB09037	Pembrolizumab	2	Completed	1
DB09037	Pembrolizumab	2	Recruiting	1
DB11836	Sapanisertib	2	Active Not Recruiting	1
DB11119	Sodium iodide	2	Active Not Recruiting	1
DB00759	Tetracycline	2	Active Not Recruiting	1
DB01030	Topotecan	2	Active Not Recruiting	1
DB11771	Tremelimumab	2	Active Not Recruiting	1
DB04849	Cediranib	2 / 3	Active Not Recruiting	1
DB00997	Doxorubicin	2 / 3	Active Not Recruiting	2
DB01006	Letrozole	2 / 3	Active Not Recruiting	1
DB09074	Olaparib	2 / 3	Active Not Recruiting	1
DB01229	Paclitaxel	2 / 3	Active Not Recruiting	2
DB00675	Tamoxifen	2 / 3	Active Not Recruiting	1
DB00759	Tetracycline	2 / 3	Active Not Recruiting	2
DB01030	Topotecan	2 / 3	Active Not Recruiting	2
DB08911	Trametinib	2 / 3	Active Not Recruiting	1
DB00112	Bevacizumab	3	Active Not Recruiting	2
DB00112	Bevacizumab	3	Completed	2
DB00958	Carboplatin	3	Active Not Recruiting	3
DB00958	Carboplatin	3	Completed	2
DB14547	Chloride ion	3	Completed	1
DB00515	Cisplatin	3	Completed	1
DB01248	Docetaxel	3	Active Not Recruiting	1
DB00441	Gemcitabine	3	Active Not Recruiting	1
DB00142	Glutamic acid	3	Active Not Recruiting	1
DB04964	Oregovomab	3	Active Not Recruiting	1
DB01229	Paclitaxel	3	Active Not Recruiting	4
DB01229	Paclitaxel	3	Completed	2
DB13809	Paclitaxel poliglumex	3	Active Not Recruiting	1
DB12257	Platinum	3	Completed	1